NASDAQ$MYGN
Myriad Genetics Inc · Q3 2022 earnings
Q3 2022 earnings · · Investor relations
Briefing
Myriad Genetics reported third quarter financial results.
Myriad Genetics' third quarter revenue was $156.4 million. GAAP EPS was $(0.43) and adjusted EPS was $(0.19). The company acquired Gateway Genomics, LLC for $67.5 million cash and up to an additional $32.5 million of cash consideration.
- Revenue of $156.4 million for the quarter ended September 30, 2022.
- Third quarter testing volumes, excluding divested businesses, grew 12% year-over-year.
- Diluted GAAP earnings per share (EPS) were $(0.43) and adjusted EPS were $(0.19) in the third quarter of 2022.
- Acquired Gateway Genomics, LLC, a leading private developer of consumer genetic tests serving the women’s health market for $67.5 million cash and up to an additional $32.5 million of cash consideration.
Headline financials
Revenue & EPS history
Myriad Genetics · Revenue · Quarterly
$156M
Revenue by segment
Myriad Genetics · $123M total across 3 segments · Q3 2022
- Hereditary Cancer$70.5M-11.2%57.1%
- Tumor Profiling$30.8M-6.4%25.0%
- Prenatal$22.1M-6.4%17.9%
Forward guidance
Myriad Genetics updated full year 2022 financial guidance to reflect third quarter business updates.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2022
-2.7%
Avg return
Earnings day
-6.0%
Avg return
5 days after
-4.5%
Avg return
30 days after
45%
29 / 65 earnings
Positive
+20.4%
Q3 2017
Best reaction
-43.7%
Q4 2019
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -18.3% | -16.3% | -9.1% | |
| Q4 2025 | +5.7% | +5.3% | +5.5% | |
| Q3 2025 | -21.0% | -23.0% | -10.4% | |
| Q1 2025 | -41.3% | -41.5% | -30.0% | |
| Q4 2024 | -14.8% | -22.1% | -33.1% | |
| Q3 2024 | -0.9% | -8.0% | -13.9% | |
| Q2 2024 | +3.1% | +8.2% | +7.0% | |
| Q1 2024 | +19.9% | +27.5% | +11.7% | |
| Q4 2023 | -5.8% | -3.3% | -7.0% | |
| Q3 2023 | +4.3% | -3.3% | +5.6% | |
| Q2 2023 | -9.3% | -19.9% | -15.4% | |
| Q1 2023 | -0.8% | -13.8% | +10.2% | |
| Q4 2022 | +14.6% | +24.5% | +20.5% | |
| Q3 2022 | -21.4% | -20.3% | -1.9% | |
| Q2 2022 | +5.9% | +1.0% | -15.9% | |
| Q1 2022 | -1.6% | -9.1% | -11.7% | |
| Q4 2021 | +3.7% | -1.3% | +6.5% | |
| Q3 2021 | -6.1% | -1.5% | -18.1% | |
| Q2 2021 | +12.8% | +11.6% | +16.9% | |
| Q1 2021 | +4.6% | -6.5% | -6.8% | |
| Q4 2020 | -3.1% | +8.6% | +1.7% | |
| Q3 2020 | -6.7% | -4.1% | +4.4% | |
| Q2 2020 | -28.8% | -33.2% | -44.6% | |
| Q1 2020 | -38.1% | -30.1% | -23.6% | |
| Q4 2019 | -43.7% | -44.0% | -39.0% | |
| Q3 2019 | -22.9% | -19.9% | -28.9% | |
| Q2 2019 | +3.3% | +6.1% | +4.3% | |
| Q1 2019 | -14.3% | -19.5% | -16.1% | |
| Q4 2018 | +15.0% | +16.0% | +13.0% | |
| Q3 2018 | +15.1% | +20.3% | +35.0% | |
| Q2 2018 | -1.7% | -4.2% | -7.5% | |
| Q1 2018 | -0.6% | +4.1% | +9.1% | |
| Q4 2017 | +11.0% | +10.1% | +28.6% | |
| Q3 2017 | +20.4% | +19.8% | +9.5% | |
| Q2 2017 | +6.6% | +3.2% | +23.6% | |
| Q1 2017 | -16.8% | -16.4% | -15.6% | |
| Q4 2016 | -34.3% | -28.2% | -32.4% | |
| Q3 2016 | -7.4% | — | — | |
| Q2 2016 | -7.1% | — | — | |
| Q1 2016 | +10.2% | — | — | |
| Q4 2015 | +5.0% | — | — | |
| Q3 2015 | -2.5% | — | — | |
| Q2 2015 | -7.4% | — | — | |
| Q1 2015 | -12.3% | — | — | |
| Q4 2014 | -5.8% | — | — | |
| Q3 2014 | -10.0% | — | — | |
| Q2 2014 | +14.1% | — | — | |
| Q1 2014 | -0.0% | — | — | |
| Q4 2013 | -7.7% | — | — | |
| Q3 2013 | +9.0% | — | — | |
| Q2 2013 | -2.6% | — | — | |
| Q1 2013 | +13.5% | — | — | |
| Q4 2012 | -1.0% | — | — | |
| Q3 2012 | +1.7% | — | — | |
| Q2 2012 | +3.1% | — | — | |
| Q1 2012 | -0.7% | — | — | |
| Q4 2009 | +4.7% | — | — | |
| Q4 2011 | +4.7% | — | — | |
| Q3 2010 | +5.7% | — | — | |
| Q3 2011 | +5.7% | — | — | |
| Q2 2011 | -0.7% | — | — | |
| Q2 2010 | -0.7% | — | — | |
| Q1 2010 | +5.5% | — | — | |
| Q1 2011 | +5.5% | — | — | |
| Q4 2010 | +5.5% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro